Search results
The pathophysiology of coronavirus disease 19 (COVID-19) and diabetes mellitus are interlinked, and diabetes mellitus is associated with severe COVID-19 outcomes. This Review highlights new advances in diabetes mellitus and COVID-19, considering disease mechanisms and clinical management of patients with diabetes mellitus in the ongoing pandemic.
19 maj 2023 · To provide a systematic overview of the current body of evidence on high-risk phenotypes of diabetes associated with COVID-19 severity and death. Methods. This is the first update of our recently published living systematic review and meta-analysis.
8 sie 2024 · This review describes diabetes mellitus and its complications, explains the risk factors, such as disease characteristics and patient lifestyle, which may contribute to the high susceptibility of diabetic patients to COVID-19, and discusses preventive and therapeutic strategies for COVID-19-positive diabetic patients.
18 cze 2024 · Epidemiological studies and meta-analyses reported an increase in the incidence of type 1 diabetes mellitus during the COVID-19 pandemic as well as an association between SARS-CoV-2...
1 paź 2021 · Patients with Covid-19 place new challenges on the management of type 2 diabetes, including the questions of whether glucose-lowering therapy should be adjusted during infection and how to manage a return to normal care after resolution of Covid-19 symptoms.
23 cze 2021 · While diabetes does not seem to be associated with an increased risk of COVID19 infection per se, it has been clearly demonstrated that the presence of hyperglycemia of any degree predisposes to...
Preexisting Diabetes Is Associated with Poor Outcomes of COVID-19. Emerging information suggests that comorbid diabetes in patients with COVID-19 is associated with disease deterioration and even death.
